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Although human epidermal growth factor receptor 2 (HER2) overexpression is implicated in tumor
progression for a variety of cancer types, how it dysregulates signaling networks governing cell
behavioral functions is poorly understood. To address this problem, we use quantitative mass
spectrometry to analyze dynamic effects of HER2 overexpression on phosphotyrosine signaling in
human mammary epithelial cells stimulated by epidermal growth factor (EGF) or heregulin (HRG).
DatageneratedfromthisanalysisrevealthatEGFstimulationofHER2-overexpressingcellsactivates
multiple signaling pathways to stimulate migration, whereas HRG stimulation of these cells results
in ampliﬁcation of a speciﬁc subset of the migration signaling network. Self-organizing map
analysis of the phosphoproteomic data set permitted elucidation of network modules differentially
regulated in HER2-overexpressing cells in comparison with parental cells for EGF and HRG
treatment. Partial least-squares regression analysis of the same data set identiﬁed quantitative
combinations of signals within the networks that strongly correlate with cell proliferation and
migration measured under the same battery of conditions. Combining these modeling approaches
enabled association of epidermal growth factor receptor familydimerization to activation of speciﬁc
phosphorylation sites, which appear to most critically regulate proliferation and/or migration.
Molecular Systems Biology 3 October 2006; doi:10.1038/msb4100094
Subject Categories: proteomics; signal transduction
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Introduction
Human epidermal growth factor receptor 2 (HER2), also
known as Erb-B2, belongs to the epidermal growth factor
receptor (EGFR) family of highly regulated receptor tyrosine
kinases (RTKs) composed of human epidermal growth factor
receptors1, 2, 3, and 4 (EGFR, HER2, HER3, and HER4). These
receptorsaredifferentiallyboundby11ligands,althoughsofar
no ligand has been found to bind HER2. Mutation and
dysregulation of EGFR family members has been correlated
with cancer development and progression (Yarden and
Sliwkowski, 2001; Mendelsohn and Baselga, 2003), and
overexpression of HER2 has been found in association with
a variety of tumor types (Hynes and Lane, 2005). The
connection between HER2 and cancer appears to be especially
important in breast cancer (Lemmon, 2003), with current
estimates of prevalence on the order of 25–30% of patients
includingmetastasesaswellasprimarytumors(Carlssonetal,
2004) and notable correlation with poor prognosis (Citri et al,
2003). For instance, one recent review has concluded that
HER2/neu gene ampliﬁcation or HER2 protein overexpression
can predict breast cancer outcome for 90% of the studies and
92% of the patients in 81 studies including 27161 patients
(Ross et al, 2003).
Although HER2 appears to have no intrinsic ligand-binding
capability, it can interact reversibly with ligand-activated
EGFR or HER3 to form active heterodimers that perturb and
often enhance the downstream signals that govern cell
proliferation and migration (Hynes and Lane, 2005). At high
concentrations, HER2 is also thought to spontaneously form
signaling-competent homodimers (Harari and Yarden, 2000).
In the case of HER2–EGFR heterodimers, signaling proceeds
through phosphorylation events initiated from either of the
activated receptors. In contrast, HER2–HER3 heterodimer
signaling proceeds only through the activated HER2 receptor,
as HER3 does not exhibit kinase activity itself. HER2 is
considered responsible for at least the vast majority of
downstream signals induced by HER3-ligand binding (Holbro
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Article number: 54et al, 2003), although there is some evidence of HER3–EGFR
signaling heterodimers (Knowlden et al, 2003). Activation
of HER2–HER3 heterodimers, generally considered to be the
most potent signaling pair of EGFR family dimers (Pinkas-
Kramarski et al, 1996), is tightly regulated (Citri et al, 2003),
and HER2 overexpression has been found to mediate
enhanced signaling caused by heregulin (HRG) stimulation
(Aguilar et al, 1999). Various studies have shown that HRG-
stimulated HER3 activation in breast cancer can induce
anti-estrogen resistance, tumor progression, invasion, and
metastasis (Yao et al, 2001; Atlas et al, 2003; Tsai et al, 2003).
Taken together, the high correlation between EGFR family
member dysregulation and cancer progression highlights the
need for mechanistic understanding of the underlying cellular
networks, both for improved basic knowledge of cancerand to
ﬁnd new and more effective drug targets.
Signal generation and resultant cellular behavior in RTK-
initiated cascades is achieved through a highly coordinated
series of events. Receptorsareﬁrst activated, typically through
ligand binding, which results in receptor autophosphorylation
and leads to the dynamic phosphorylation/dephosphorylation
of a variety of proteins. The dynamic state of protein
phosphorylation ultimately controls cellular response, and
a given protein may inﬂuence more than one response as it
becomes phosphorylated at different sites or interacts with
different proteins depending on timing and placement within
the cell. Thus, to understand cellular signaling in the context
of cell regulation, it is helpful to quantify phosphorylation
dynamics of regulatory sites and their consequent association
with downstream cell functions. Our work presented here
offers, to our knowledge, the mostdetailed explanation of how
signaling network phosphorylation, in the context of HER2
overexpression, governs cellular behavior such as prolifera-
tion and migration across a diverse set of ligand stimulation
conditions.
To identify important epidermal growth factor (EGF)- and
HRG-induced protein phosphorylation events that control cell
migration and proliferation in the context of HER2 over-
expression, we utilized a mass spectrometry (MS) approach
that is capable of simultaneously quantifying the temporal
dynamics of a large number of speciﬁc tyrosine phosphoryla-
tion sites under a given condition (Zhang et al, 2005b). Here,
we extend this methodology to measure temporal dynamics
of protein tyrosine phosphorylation sites following EGFR
or HER3 stimulation in the presence and absence of HER2
overexpression. Protein phosphorylation sites are clustered
based on similarity of dynamic response to different stimula-
tion conditions across four time points for all four conditions
(self-organizing map (SOM)), revealing co-regulated phos-
phorylation sites and providing potential functionality for
several novelphosphorylation sites.In addition to MS analysis
of protein phosphorylation, biological response data (cell
migration and proliferation) were quantiﬁed for each of the
four stimulation conditions. To identify signals that regulate
downstream biological response to a given stimulus, compu-
tationalmethodswereusedtocorrelatebiologicalresponsesto
quantitative phosphoproteomics data. Phosphorylation sites,
which correlate strongly with proliferation or migration, were
identiﬁed and may be targeted in future studies to selectively
inhibit a given response.
Results and discussion
Phosphotyrosine MS of parental and HER2-
overexpressing HMECs in response to EGF
and HRG treatment
We have undertaken a quantitative investigation of the effects
of HER2 overexpression in a human mammary epithelial cell
(HMEC) line (184A1; Stampfer and Bartley, 1985). We
compared the parental line (denoted ‘P’), which exhibits
approximately 200000 EGFR per cell, 20000 HER2 per cell,
and 20000 HER3 per cell, to a stable retrovirally transduced
clone (denoted ‘24H’) that expresses HER2 at 600000 per cell
while maintaining constant EGFR levels and increased HER3
levels to about 30000 per cell. We have previously performed
combined experimental and modeling studies on this cell line
enabling quantitative estimation of the various receptor dimer
species under various treatment conditions (Hendriks
et al, 2003a, 2005). From our previous work, we expect that
100ng/ml EGF treatment should result in high levels of EGFR
homodimersin thePHMECs (B80000),but lower numbersof
EGFR–HER2heterodimers(B20000).Bycomparison,treating
24H HMECs with this same concentration of EGF should drive
a large increase in heterodimers (to B150000) and a
signiﬁcant decrease in EGFR homodimers (B10000). HRG
treatment at 80ng/ml should yield B15000 HER2–HER3
heterodimers in the P HMECs, and in the 24H HMECs this
number should increase to B25000. Interestingly, under both
ligand treatments, 24H HMECs are expected to have large
numbers of HER2 homodimers (4B200000), some of which
may be activated through basal autophosphorylation. Here,
we explore the consequences of these changing dimerization
states on intracellular signaling and the subsequent control of
cell proliferation and migration. We have acquired MS data
describing the temporal dynamics (0, 5, 10, and 30min
stimulation) of tyrosine phosphorylation in the 184A1 cell
system under four conditions: P HMECs stimulated with EGF,
P HMECs stimulated with HRG, 24H HMECs stimulated with
EGF, and 24H HMECs stimulated with HRG (see Figure 1).
As a result of these analyses, 332 phosphorylated peptides
from 175 proteins were identiﬁed, including 289 singly
(tyrosine) phosphorylated peptides, 42 doubly phosphory-
lated peptides (21 tyrosine/tyrosine, 18 serine/tyrosine, and
three threonine/tyrosine), and one triply phosphorylated
peptide (tyrosine/tyrosine/tyrosine) (full data set is available
in Supplementary information). A total of 20 phosphorylation
siteswereidentiﬁedonEGFR,HER2,andHER3,includingnine
tyrosine and two serine sites on EGFR, eight tyrosine
phosphorylation sites on HER2, and one tyrosine phosphor-
ylation site on HER3 (Figure 1B–D). Of the 20 phosphorylation
sites on EGFR family members, Y1114 on EGFR and Y1005 and
Y1127 on HER2 represent novel sites that have not been
previously described in the literature, although synthetic
phosphopeptides containing EGFR Y1114 and HER2 Y1005
have been shown to bind SHC (Schulze et al, 2005) and
mutation of EGFR Y1114 has been shown to block SOCS
recruitment to the receptor, regulating STAT activation (Xia
et al, 2002). Downstream of the receptors, quantitative data
were obtained for 36 phosphorylation sites on 15 different
proteins in the EGFR canonical signaling pathway (as deﬁned
HER2-induced cell signaling networks
A Wolf-Yadlin et al
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adhesion/migration pathway included quantitative informa-
tion on 41 phosphorylation sites distributed along 16 proteins,
including nine tyrosine phosphorylation sites on d-catenin.
One of the goals in this study was to provide a more
comprehensive deﬁnition of EGFR family signaling networks,
including novel proteins or phosphorylation sites that may
regulate differential cellular response to exogenous stimuli.
To enable identiﬁcation of novel phosphorylation sites, MS
analyses were performed in an information-dependent acqui-
sition mode (automated selection of the most abundant
species in a given full scan mass spectrum for MS/MS
analysis), rather than targeting speciﬁc peptides and known
phosphorylation sites for quantiﬁcation. This data-dependent
mode of operation was successful at identifying novel proteins
and phosphorylation sites, as 122 of the 322 phosphorylation
sites have not previously been described in the literature.
Unfortunately, the use of automated ion selection to discover
novel phosphorylation sites often precluded selection of
low-abundance precursor ions for MS/MS fragmentation, and
thereforetemporalphosphorylation proﬁleswerenotobtained
forallconditionsformanypeptides.Infact,234ofthe322sites
inthisworkweredetected andquantiﬁedinmultiple analyses,
but only 68 were quantiﬁed for all four stimulation conditions
and the 5min comparison. This core group of 68 phosphopep-
tides, which include many of the key signaling nodes in the
network, was then used for further computational analysis to
obtain a mechanistic understanding of the effects of HER2
overexpression on cellular signaling networks and corre-
sponding biological response to growth factor stimulation.
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Figure1 Dataacquisitionandquantiﬁcationschemewithexampledata.(A)184A1parentalHMECcellsand24HHMECcellswerestimulatedwitheitherEGForHRG
for 0, 5, 10, or 30min. For each stimulation condition, following cell lysis and tryptic digestion, peptides from each time point were labeled with iTRAQ, mixed, and
analyzed by anti-phosphotyrosine peptide immunoprecipitation and immobilized metal afﬁnity chromatography–liquid chromatography tandem mass spectrometry
(IMAC–LC-MS/MS), producing temporal tyrosine phosphorylation proﬁles for hundreds of peptides. To normalize temporal proﬁles from each condition, tryptic peptides
from the 5min stimulation time pointfor each condition were labeled with iTRAQ, mixed, and analyzed by anti-phosphotyrosine peptide immunoprecipitation and IMAC–
LC-MS/MS. (B) For each peptide, y- and b-type ions in the MS/MS spectrum provided sequence identiﬁcation and site assignment, whereas the iTRAQ marker ion
region(highlightedintheredoval)provided quantiﬁcation.(C)iTRAQmarkerionproﬁlesrepresenting temporalphosphorylationproﬁlesfor EGFRpY1148underallfour
conditions(topleft) aswell asthe relative amountofphosphorylationfollowing a5minstimulationforeachcondition(topright).Theﬁnalplotoftemporalresponse under
multiple stimulation conditions (bottom) was generated by multiplying each temporal phosphorylation proﬁle by the value obtained from the 5min mix quantiﬁcation data
fortheparticularstimulationcondition. (D)Multiple tyrosine phosphorylationsites wereidentiﬁedandquantiﬁedfromEGFR familymemberproteins. Fourrepresentative
phosphorylation sites are shown here, with response plots across temporal and conditional space. As can be seen by comparing HER2 pY877 and pY1248, different
sites on a given protein are often differentially regulated.
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conditionally related clusters of phosphorylation
sites
In order to identify clusters of tyrosine-phosphorylated
peptides exhibiting similar temporal dynamics, as well as to
globally visualize the high-dimensional information we have
obtained, we used the SOM algorithm (Kohonen, 2001). The
SOM is a versatile clustering algorithm that transforms high-
dimensional data into lower dimensional display, in a non-
linear manner. Here, we use the uniﬁed-distance matrix (or
U-matrix) approach, which allows robust identiﬁcation of
clusters, and the component plane representation, which
facilitates comparison of peptide phosphorylation response to
exogenous stimuli (Ultsch and Siemon, 1990; Kohonen, 2001).
Instead of taking a single map unit as one cluster, we use
U-matrix to identify groups of map units that together
comprehend a cluster. The U-matrix illustrates the mean
distances between neighboring map units after the SOM
training phase. These distances are color-coded so that close
proximity of two map units is colored with bluish colors,
whereas shades of yellow and red denote dissimilarity.
Clusters can be identiﬁed as continuous bluish regions
(valleys) surrounded by yellow or red ‘mountains.’
We applied this SOM algorithm to 62 ‘core’ phosphorylated
peptides for which temporal proﬁles were generated under all
conditions (six of the ‘core’ phosphorylated peptides had
minimal response across all conditions and time points and
were removed from this analysis). Data were normalized with
thez-scoremethod across all timepoints and conditions.From
the U-matrix in Figure 2, four clusters are readily identiﬁable.
Statistical signiﬁcances for these clusters were computed with
a permutation test-based method (Hautaniemi et al, 2003) and
the clusterswere found to be statisticallysigniﬁcant (Po0.05).
The entire SOM display including the component planes is
given in Supplementary information.
By comparing the individual phosphorylation proﬁles
(Figure 2, blue dashed lines) or average phosphorylation
proﬁle (Figure 2, red line) within each cluster, it is clear that
the algorithm has clustered peptides whose phosphorylation
level is increased under selected conditions, information that
can be used to link phosphorylation sites within a cluster to
activated receptor homo- or heterodimers. For instance, the
ﬁrst cluster (c1 in Figure 2) consists of 18 peptides whose
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Figure 2 SOM to cluster phosphorylation sites across conditional and temporal space. Phosphorylation levels for 62 core phosphorylated peptides, which were
detected and quantiﬁed at four time points for each of the four stimulation conditions and the 5min mix analysis, were normalized and placed into an SOM. Four
statistically signiﬁcant clusters were identiﬁed in the SOM (circled bluish valleys surrounded by yellow ‘mountains’). The components for each of the four clusters are
indicated in the ﬁgure along with the phosphorylation proﬁles (blue dashed lines) and an average proﬁle for each cluster (red line) across conditions and time points (16
dimensions).
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stimulation of P or 24H HMECs, conditions that would lead to
activation of EGFR homodimers or EGFR–HER2 heterodimers,
respectively. Correspondingly, most of the proteins in this
cluster have been previously associated with proliferation and
early response to EGF stimulation, including EGFR Y1068 and
Y1148, STAT-3 Y705 (STAT-3 isoform 1) and Y704 (STAT-3
isoform 2), SHIP-2 Y986, SHC Y239, Y240 and Y317 and early
effectors downstream of them, including MAP kinases ERK2
(phosphorylated at Y187 and at T185 and Y187), Erk1 Y204,
and p38a Y182.
In comparison to c1, the three other clusters in the U-matrix
(c2–c4)containpeptideswhosephosphorylationappearstobe
regulated by HER2 activation, as phosphorylation levels on
these peptides are highest when HER2 is overexpressed. More
speciﬁcally, peptides in the second cluster (c2) are primarily
phosphorylated downstream of EGFR–HER2 heterodimers, as
the highest levels of phosphorylation occur in the 24H HMECs
stimulated with EGF. This cluster consists of SHB Y355, SHP-2
Y62, LDL receptor Y845, and three EphA2 tyrosine sites,
including the activation loop at Tyr 772 (Kinch and Carles-
Kinch, 2003). Of these proteins, only SHP-2 has been
previously associated with EGFR activation (Qu et al, 1999).
Interestingly, each of the other proteins has been associated
with the cell migration response to VEGF stimulation (Cheng
et al, 2002; Holmqvist et al, 2003; Prager et al, 2004), a
responsethatrequiresEGFautocrinesignalingfollowingVEGF
stimulation in endothelial cells (Semino et al, 2006). Our data
link these phosphorylation sites to the EGFR family signaling
network, and as demonstrated below, show strong correlation
between these phosphorylation sites and cell migration in
response to EGF stimulation of 24H HMECs.
The third cluster (c3) contains three peptides that are
primarily phosphorylated downstream of activated HER2–
HER3 heterodimers, as implicated by maximal phosphoryla-
tion levels following HRG stimulation of 24H HMECs. This
cluster includes phosphorylation of p130Cas at Y327 and
Y387, and phosphorylation of BCAR3 at Y267. Both of these
proteins are part of the same family and have been shown to
regulate or be regulated by Src activity in the cell migration
signaling network. Similar to c2 and c3, peptides in the fourth
cluster (c4) are predominantly phosphorylated downstream of
HER2, but are equally phosphorylated downstream of EGFR–
HER2 or HER2–HER3 heterodimers or possibly activated
through active HER2 homodimers (similar phosphorylation
levels are seen in EGF- or HRG-stimulated 24H HMECs). This
cluster includes phosphorylation of retinoic acid-induced
protein 3 (RAI3) Y347, paxillin Y118, GIT1 Y545, FAK Y397
and Y576, receptor protein tyrosine phosphatase alpha
(RPTPa) Y798, PI3K Y464, and insulin-like growth factor
receptor (IGF-1R) Y1161 and Y1165. A complex containing
GIT1 and paxillin has been shown to regulate cell motility,
possibly through recruitment of PAKor PIX to the leading edge
(Manabe et al, 2002); the role of tyrosine phosphorylation in
this process has not been established. Other proteins in this
cluster have also been shown to be co-regulated, as RPTPa has
recently been shown to regulate integrin signaling through Src
activation in a PI3K-dependent manner downstream of insulin
activation (Vulin et al, 2005), and Src activation is known to
regulate tyrosine phosphorylation of FAK. It is worth noting
that the phosphorylation sites on IGF-1R (Y1161 and Y1165)
occur within a peptide that is homologous to the insulin
receptor. Although not conclusive, assignment to IGF-1R is
based on the presence of a phosphorylation site on a peptide
speciﬁc for IGF-1R in the larger data set and greater levels of
IGF-1R as compared to insulin receptor on HMEC parental and
24H cells (HS Wiley, personal communication). Activation of
IGR-1R has been found to be correlated with increased motility
in a breast cancer cell line (Zhang et al, 2005a); in our system,
increased phosphorylation is most likely associated with
autocrine release and binding of IGF-1 following stimulation
of EGFR family members.
From these clusters, it is clear that analyzing phosphoryla-
tion sites across 16 dimensions of temporal and conditional
space can reveal co-regulated phosphorylation sites, and that
this information can be used to connect phosphorylation of
speciﬁc sites to activation of EGFR family member dimers.
Although clusters 3 and 4 both contain phosphorylation sites
from proteins known to regulate migration, they are statisti-
callydistinctclusterswhosedifferentialresponsetoexogenous
stimuli may be owing to protein subcellular localization, as
proteins from cluster 4 are known to be associated with the
membrane, whereas proteins in cluster 3 are primarily
cytosolic. SOM-based data analysis can reveal interesting
hypotheses and connectivity in the data, such as the potential
role of GIT1 Y545 affecting cell migration or the inclusion of
PTPRa, PI3K, and IGF-1R phosphorylation sites in a single
cluster, but it is still necessary to relate phosphorylation and
phenotypic data to solidify these hypotheses.
Cell proliferation and migration are differentially
stimulated via EGFR and HER2
In order to correlate signaling data with cellular response,
we quantiﬁed both cell migration and cell proliferation in the
HMEC parental and 24H cell lines. Measurements were
obtained under serum-free, HRG-stimulating (80ng/ml), or
EGF-stimulating (100ng/ml) conditions.
Cell migration was measured using a wound-closure assay
adapted for a 96-well plate format and automated ﬂuorescent
imaging. Under all conditions investigated, the 24H cells
movedmorerapidlyintotheinducedwound,therebyreducing
the original wound area at a greater ratethan the parental cells
(Figure 3A–C). The wound closure trajectories were ﬁt to a
line, and the slopes were the input for partial least-squares
modeling. Interestingly, the greatest difference between the
two cell lines occurs during EGF treatment. By comparison,
HRG stimulation, while inducing a slightly higher rate of
wound closure for 24H HMEC relative to P HMEC, does not
seem to drive signiﬁcantly enhanced migration relative to
serum-free conditions.
Cell proliferation was measured by [
3H]thymidine uptake
25h after ligand stimulation. Figure 3D shows that EGF
treatment increased thymidine uptake to a greater extent than
did HRG treatment, but both treatments induced higher
amounts of proliferation than seen in serum-free conditions.
In direct contrast to the migration phenotype, there was no
signiﬁcant difference (i.e., Pb0.05 in all cases) between the
two cell types measured under any of the stimulation
HER2-induced cell signaling networks
A Wolf-Yadlin et al
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facilitate enhanced proliferation in any of the conditions
probed.
The fact that HER2 overexpression mediated differences in
migration, particularly under EGF-stimulating conditions, but
did not do so for proliferation indicates that some of the
signaling molecules differentially regulated by HER2 expres-
sion levels play a role in driving higher levels of migration
while at the same time remaining agnostic to cell proliferation.
The linear regression modeling discussed below integrates our
quantitative migration, proliferation, and signaling data to
describe, among other things, a set of signaling molecules that
is most relevant for the changes in migration induced by HER2
overexpression.
Modulation of EGFR signaling network by HER2
To assess the effect of increased HER2 expression levels on the
canonical EGF-activated pathway, the phosphorylation level
for sites observed in EGF-stimulated 24H cells was divided by
the phosphorylation level for the same site and stimulation
time in EGF-stimulated parental cells, producing a fold change
in phosphorylation level for a given site and time. A subset of
the proteins and phosphorylation sites within the canonical
EGFR signaling network are shown in Figure 4A. As is evident
from this ﬁgure, increased HER2 expression affects most
phosphorylation sites on selected proteins in the EGFR
signaling network, but not all phosphorylation sites on a
given protein react equally to this perturbation. For instance,
each of the multiple phosphorylation sites on EGFR exhibits
different regulation at low or high HER2 expression levels,
including increased phosphorylation of Y974 and decreased
phosphorylation on Y1045 under HER2 overexpression as
compared with basal HER2 expression. Both of these sites
appear to regulate receptor internalization and degradation:
Y974A or Y974F mutations have been shown to decrease
receptor internalization rates (Sorkin et al, 1996), and Cbl
(E3-ubiquitin ligase) binding to EGFR Y1045 is required for
lysosomal sorting and receptor degradation (Grovdal et al,
2004). Decreased phosphorylation at the Y1045 site should
lead to decreased ubiquitination of activated EGFR, thereby
providing a mechanism for the observed increase in recycling
of activated EGFR in the 24H cell line relative to parental
184A1 HMECs (Hendriks et al, 2003b).
Itisalsointerestingtonotethehigherbasalphosphorylation
level for selected sites in the 24H cell lines relative to parental
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Figure 3 EGF and HRG drive migration and proliferation to varying extents in HMEC parental and HER2-overexpressing cells. Parental (black) and 24H (red) wound
healing data shown for (A) serum-free conditions, (B) treatment with 100ng/ml EGF, and (C) treatment with 80ng/ml HRG. (D) Proliferation, as measured by
[
3H]thymidine incorporation, for both cell types under the treatment conditions shown in (A–C).
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HER2 overexpression could be mediated by HER2 autophos-
phorylation, crossphosphorylation of EGFR in the absence of
ligands, or even through increased autocrine stimulation of
HER2 heterodimers. For most sites with high levels of basal
phosphorylation in the 24H cells, stimulation with saturating
concentrations of EGF typically resulted in a greater response
in parental cells relative to 24H cells, such that after EGF
stimulation for 5min many of the sites had similar levels of
phosphorylation in both cell lines. A speciﬁc example of this
behavior is provided by phosphorylation of the ERK2
activation loop (Y185 and T185/Y187). Much higher levels
of basal phosphorylation were detected in the 24H cells
relative to parental cells, but only a slight difference in
phosphorylation at these sites remained after 5min of EGF
stimulation. These resultsareconsistent with our proliferation
data, in which no signiﬁcant difference between 24H and
parentalcellsunder EGF stimulationwasobserved,in contrast
to serum-free 24H cells, which had greater proliferation than
parental HMECs (Po0.1). These results are also consistent
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Figure 4 Effect of increased HER2 expression on phosphorylation sites within the EGFR signaling network. Visualization of the fold change in phosphorylation level
between 24H and parental cells stimulated with EGF provides a network view of the mechanistic effects of HER2 overexpression on (A) the canonical EGFR signaling
cascades and (B) the cell migration-associated signaling pathway.
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activator of proliferation (Cobb et al, 1994). In fact, many
protein phosphorylation sites associated with proliferation
behavesimilarlytoERK2inoursystem,including STAT-3Y705
(and Y704 from STAT-3 isoform 2), EGFR Y1173, and SHC
Y239, Y240, and Y317.
As HER2 overexpression has been found to affect cell
motilityin ourstudyaswellasinpreviouswork(Spenceretal,
2000), the effect on protein phosphorylation in a subset of the
pathways related to cell migration is shown in Figure 4B. From
this ﬁgure, it is clear that there is an overall increase in
phosphorylation of many of these pathway proteins in the
presence of HER2 overexpression. Perhaps most striking is the
increaseinphosphorylationforallofthephosphorylation sites
detected on catenin-d and catenin-g. Catenins are known to
interactwithE-cadherin,themaincell–celladhesionproteinin
epithelial cells (Davis et al, 2003). Catenin-d, a member of the
p120 catenin family, has been shown to regulate E-cadherin
turnover by modulating its internalization and degradation
rate (Davis et al, 2003), stabilizing it on the cell surface when
bound to it. HER2 overexpression in breast carcinomas
inhibits the transcription of E-cadherin (D’Souza and Taylor-
Papadimitriou, 1994) and has also been found to destabilize
the catenin–cadherin complex, leading to decreased adhesion
(Jawhari et al, 1999). Also, EGFR has been found to directly
phosphorylate p120 catenin at Y228 (Mariner et al, 2004), and
EGFR inhibition was found to promote assembly of cell
adhesions (Lorch et al, 2004). The accumulated evidence of
thesereportsisconsistentwithourdataasitarguesthatSrc-or
RTK-related phosphorylation of catenin-d leads to separation
of the catenin–cadherin complex, resulting in destabilization
of E-cadherin and an increase in cell migration. Tyrosine
phosphorylation of catenin-g has also been related to loss
of cell–cell adhesions in EGF-stimulated, E-cadherin-positive
cervical cancer cells (Moon et al, 2001). Our data show high
levels of phosphorylation of catenin-d and catenin-g in HER2-
overexpressing cells under EGF stimulation, directly contri-
buting to loss of cell adhesion and an increase in cell motility.
Although catenin phosphorylation and loss of E-cadherin-
based cell–cell adhesion may provide part of the migratory
response following EGF stimulation in 24H cells, increased
phosphorylation of many additional components of the cell
migration pathways is also likely to be contributing to
increased migration of these cells relative to parental cells.
For instance, FAK, Src, paxillin, and p130Cas have all been
shown to interact with each other, to localize at the focal
adhesions, and to play a fundamental role in the actin
cytoskeleton reorganization and motility pathways (Webb
et al, 2004). Phosphorylation of paxillin (Y31) and (Y118) is
known to regulate membrane spreading and rufﬂing in cell
migration and adhesion (Tsubouchi et al, 2002). FAK and Src
are two of the major kinases involved in cell migration. FAK
(Y397) is the major autophosphorylation site and acts as a
dockingsiteforSrcandPI3K(CaryandGuan,1999);thissiteis
also necessary for both p130cas and paxillin phosphorylation
inresponsetoFAKexpression(CaryandGuan,1999).SrcY418
is a major Src autophosphorylation site, whose phosphoryla-
tionresultsinself-activation(Roskoski,2004).Srccanmediate
FAK-related migration by further phosphorylation of paxillin
or p130Cas, which may result in focal adhesion turnover and/
orlamellipodiaandﬁlipodiaformationviaeithertheRAC,JNK
pathway, or the RhoGAP pathway (Playford and Schaller,
2004). We conclude that the effect of increased HER2
expression levels is partly increased interaction of FAK, Src,
P130Cas, and paxillin, a small but noticeable increase in ERK2
activity, and the upregulation of catenin phosphorylation and
thus E-cadherin turnover, all combining to drive an increased
migratory response in the 24H cell line (as in Figure 3).
HRG versus EGF stimulation in the presence
of HER2
In addition to investigating the effects of HER2 on these
pathways in Figure 5, our data also enabled comparison
of signaling downstream of activated HER2:HER3 versus
EGFR:HER2 heterodimers, resulting from stimulation of the
24HcellswithHRGandEGF,respectively.Forthisanalysis,the
phosphorylation level resulting from HRG stimulation of 24H
cells was divided by the phosphorylation level resulting from
EGF stimulation of 24H cells to produce the fold change ratio
for each phosphorylation site in the canonical signaling
pathways (Figure 5A). As expected, stimulation with HRG
instead of EGF caused a signiﬁcant increase in HER3
phosphorylation and a large decrease in EGFR phosphoryla-
tion. Perhaps not surprisingly given the relative receptor
expression levels (20000–30000copies/cell for HER3 versus
200000copies/cell for EGFR) and the kinase-dead nature of
HER3, stimulation with saturating concentrations of HRG
resulted in decreased phosphorylation of almost all down-
stream proteins as compared to stimulation with saturating
concentrations of EGF (Figure 5A). Speciﬁcally, most of the
downstream effectors that lead to proliferation (STAT-3 Y705
(Y704), ERK T202/Y204, all three phosphorylation sites on
SHC) were phosphorylated to a lesser degree under HRG
stimulation, correlating with decreased proliferation in HRG-
stimulated 24H cells as compared to EGF-stimulated 24H cells
(as in Figure 3). Other sites primarily associated with
migration (Src, PKC-d, and PI3K) do not show the same
decrease in phosphorylation when comparing HRG to EGF
stimulation of these cells. In fact, both Src and PKC-d show an
increase in phosphorylation under HRG activation at 5 and
10min, respectively. Together with our response data, these
results indicate that signaling distinct from Src, PKC-d, and
PI3K controlled pathways may govern cell migration in our
system.
To analyze the effect of HRG stimulation on the cell
migration signaling network, signaling downstream of acti-
vated HER2:HER3 versus EGFR:HER2 heterodimers was also
comparedforselectedproteinswithinasubsetofthepathways
related to cell motility (Figure 5B). Comparing phosphoryla-
tion levels for speciﬁc sites under different stimulation
conditions provides a potential hypothesis to explain the
mechanism underlying the quantitative phenotypic migration
measurements, in which EGF stimulation resulted in a
dramatic increase in migration relative to HRG stimulation of
24Hcells(seeFigure3).Giventhedifferenceinmigrationrates
between these two cell states, it is not surprising to note that
protein phosphorylation sites on almost all effectors of
migration have decreased phosphorylation levels following
HER2-induced cell signaling networks
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contrast to most proteins in the motility network, tyrosine
phosphorylation levels on FAK, p130Cas, Src, and paxillin
were increased following HRG stimulation compared to EGF
stimulation, indicating that the slight migratory effect of HRG
stimulationof24Hcellsisdirectedprimarilythroughampliﬁed
phosphorylation of a very speciﬁc pathway driven through
these four proteins.
Taken together, the data from Figures 4 and 5 demonstrate
that 24H cell migration can be induced by either broad
upregulation of the migratory pathway, including loss of cell
adhesions (24H cells under EGF stimulation) or, to a much
lesser extent, by more intense upregulation of a restricted
subset of the migratory pathway (as in 24H cells stimulated
with HRG). By comparison, 24H cell proliferationwasinduced
to a greater extent by EGF stimulation as determined by
phenotypic assay; correspondingly, phosphorylation levels
were higher on almost all proliferation-associated proteins on
24H cells stimulated with EGF as compared to 24H cells
stimulated with HRG. Also consistent with the phenotypic
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Figure 5 Effect of HRG stimulation versus EGF stimulation in high HER2-expressing cells. Visualization of the fold change in phosphorylation level between HRG-
stimulated and EGF-stimulated 24H cells provides a network view of the mechanistic effects underlying differential response to distinct growth factor stimuli on (A) the
canonical EGFR signaling cascades and (B) the cell migration-associated signaling pathway.
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dramatic for proteins in the cell migration signaling network,
as most proteins displayed a sustained increase in phosphor-
ylation levels, but was much less dramatic for proteins in the
proliferation-associated network, as increased basal phos-
phorylation levels in 24H cells were not sustained following
EGF stimulation.
Quantitative proteomics and microarray-based analyses
have been used to address the question of protein interactions
with cytosolic domain tyrosine phosphorylation sites from
EGFR family members (Schulze et al, 2005; Jones et al, 2006;
Uetz and Stagljar, 2006). Although our work is aimed at
analyzing phosphorylation dynamics in the signaling network
across different cellular environments, and therefore does not
focus on the identiﬁcation of proteins interacting with EGFR
familymembers,severalsimilaritiescanbefoundbetweenour
results and these recent publications. For instance, Jones et al
demonstrated that HER3 interacts with a small number of
downstream proteins, which is consistent with our ﬁndings
that HER3 uses a very speciﬁc set of nodes to activate the
migration pathway. Additionally, HER2 and EGFR were found
to be the most promiscuous members of the EGFR family
(Jones et al, 2006), whereas in our study EGF stimulation of
HER2-overexpressing cells promoted migration via a wide
range of phosphorylation events coupling several signaling
cascades. Overall, the proteomics approaches described by
Schultze et al and Jones et al complement the data presented
in our work by highlighting proteins directly interacting with
tyrosine phosphorylation sites on EGFR family members,
providing additional structure to the signaling network.
PLSR modeling correlates signals with cell
functional responses
We have constructed a model using partial least-squares
regression (PLSR), a method we have previously found to
be effective in relating cell signaling data to cell behavioral
response data in a quantitative and integrative manner (Janes
et al, 2005). Information obtained through our proteomic
studies was represented in an M N matrix (the X-block),
where M is the number of conditions investigated and N is the
number of peptide metrics measured. An entry in the matrix
with coordinates (i,j) represents the column j metric (i.e., ERK
Y187 phosphorylation at 5min) measured under the row i
condition (i.e., parental cell line treated with EGF). For each
condition, the metrics included in the model were phosphor-
ylation measurements at 5, 10, and 30min in addition to the
integral of this time course (with integrals being used as a
measurement for the ‘net’ phosphorylation over the 30min
timecourse).CellbehaviormeasurementscomprisedanM P
matrix (the Y-block), where M is again the number of
conditions and P is the number of behavior measurements
obtained. PLSR analysis produced a vector of coefﬁcients
indicatingtheimportanceofeachsignalingmetricwithrespect
to cellular behavior. In addition, PLSR provided a reduced-
dimension map, with axes deﬁned as linear combinations of
our original signaling metrics (Figure 6A), on which both
signals and cellular behavior can be represented. Figure 6A
shows that our original data set, consisting of 248 dimensions
(i.e., 248 protein signal metrics), has been reduced to three
dimensions using PLSR, each of which incorporates a
quantitative combination of multiple signals. The projection
of an individual signal in the direction of a given cellular
behavior in the PLS space determines how important the
phosphorylation signal is to the behavior. In Figure 6B, we list
the top 20 signals that positively correlate most strongly with
each cell behavior. Importantly, even though we can identify
smallsetsofvariablesthatcorrelatestronglywitheachcellular
output, 148 out of the 248 protein metrics had a variable
importance for projection (VIP) value of greater than 1,
indicatingthatthese148proteinmetricsplayanimportantrole
in our model (see Supplementary information for VIP
calculation). This highlights the great advantage of proteome
measurements that quantitatively capture dynamic informa-
tion ﬂow through a large number of nodes. Our model was
validated through crossvalidation and had a goodness of
prediction (Q
2) of 0.89 (see Supplementary information).
From the top 20 signal behavior covariates for proliferation
and migration in our model (Figure 6B), HER Y1248 appears
to be the main upstream activator of migration, whereas
proliferation seems to be activated by EGFR Y1173 and to a
lesser extent EGFR Y1148. This ﬁnding correlates with
literature showing that the presence of HER2 Y1248 is
necessary to induce migration of breast cancer cell lines
(Dittmar et al, 2002), whereas both EGFRY1148 and Y1173 are
Shc binding sites and thus are able to activate the ERK
signaling pathway, thereby driving proliferation (Okabayashi
et al, 1994). In this model, SHP-2 Y62 and Annexin A2 Y237,
among others, also appear to be highly correlated with
migration. Both of these proteins have previously been
implicated in regulating migration, as SHP-2 has been shown
to promote migration in MCF-7 cells by inducing loss of
E-cadherin expression and production of matrix metallo-
proteinase 9 (Wang et al, 2005a), whereas Annexin A2 has
been shown to mediate mitogenesis, cell migration, and loss
of focal adhesions when activated by tenascin-c (Chung et al,
1996; Liu et al, 2003) and it has also been identiﬁed as a major
substrate for EGFR phosphorylation (Rothhut, 1997). Inter-
estingly, treating cells with withaferin, a novel inhibitor of
Annexin A2, has recently been shown to decrease migration,
further validating the correlation betweenAnnexinA2 and cell
migration (Falsey et al, 2006).
In addition to EGFR Y1173 and Y1148, desmocollin (Dsc3a)
Y818, IGF-1R Y1165, and catenin-d Y228 (among others) are
moststronglycorrelatedwithproliferation.IGF-1Risknownto
induce cell proliferation and survival through activation of the
MAPK and PI3K pathways (Wang et al, 2005b), and has also
been associated with EGFR signaling in tamoxifen-resistant
breast cancer cell lines, potentiating their mitogenic strength
(Knowlden et al, 2003). The correlation ofDsc3a andcatenin-d
to cellular proliferation is initially surprising, as both of these
proteins are associated with cell adhesions, leading to the
expectation that they should correlate to migration instead of
proliferation. However, EGFR inhibition has been shown to
increase the presence of desmocollin and desmoglein at cell–
cell borders (Lorch et al, 2004), and EGFR has also been
shown to signal to E-cadherin complexes through phosphor-
ylation of catenin-d Y228 (Mariner et al, 2004). As the
conditional and temporal proﬁles for both of these sites
HER2-induced cell signaling networks
A Wolf-Yadlin et al
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that observed for EGFR Y1173, it can be argued that they are
either directly or closely downstream of EGFR and that
phosphorylation of these sites may destabilize cell–cell
adhesions, a step needed for both proliferation and migration.
Further biological experiments are clearly needed to more
ﬁrmly establish the functional roles of these proteins in
regulating cellular proliferation under these stimulation
conditions.
It is worth noting that a large proportion of the phosphor-
ylation events contained in our regression model inﬂuence
both migration and proliferation to some extent. Importantly,
the model provides a quantitative metric describing the
strength of correlation for each phosphorylation site relative
to migration or proliferation, data that can be used to design
further experiments to speciﬁcally perturb selected biological
outcomes—that is, to inhibit migration one might want to
target HER2, SHP-2, and EphA2. This type of data-driven
modeling can also provide insight into the functionality of
unknown proteins such as KIAA1217; in our model, phos-
phorylation of this protein at Y393 correlates strongly to
migration. Interestingly, KIAA1217 is a novel protein highly
homologous to p140CAP (p130Cas-associated protein), which
has been shown to be tyrosine phosphorylated in response
to EGF stimulation and to participate in actin cytoskeleton
organization and cell spreading (Di Stefano et al, 2004).
Combining large-scale quantitative analysis of tyrosine
phosphorylation with quantitative phenotypic measurements
has provided the means with which to understand the
relationship between these phosphorylation events and their
relationtocellularresponses.Theﬁndingswehavediscovered
here illustrate how HER2 overexpression inﬂuences signaling
Figure 6 PLSR correlates 248 protein metrics to cell migration and proliferation. (A) Visual representation of a reduced (3) dimension graph showing all 248 protein
measurementsandthecellularoutputswithcellmigration(green),cellproliferation(blue),andproteinsignals(black).(B)Listofthetop20signal–behaviorcovariatesfor
both migration and proliferation.
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and migration behavior, common to and distinct between
EGFR-binding ligand and HER3-binding ligand conditions.
This quantitative information offers unusual opportunity for
understanding prospective drug effects in a network-wide
manner, and may offer novel targets for intervening in
biological processes downstream of activated RTKs.
Conclusions
To investigate the effect of HER2 overexpression on signaling
networks and corresponding cell behavior, HMECs were
stimulated by EGF or HRG and temporal tyrosine phosphor-
ylation proﬁles were quantiﬁed by MS. To correlate signals
with cell response, proliferation and migration rates were also
quantiﬁed for these same cell states and stimulation condi-
tions. Phenotypically, HER2 overexpression promoted
increased cell migration, but had minimal effect on cell
proliferation. More speciﬁcally, EGF stimulation of HER2-
overexpressing cells promoted migration by the phosphoryla-
tion of proteins from multiple pathways (e.g., PI3K, MAPK,
catenins, and FAK), whereas HRG stimulation of HER2-
overexpressing cells activated only a very speciﬁc subset
of proteins in the canonical migration pathway, in particular
FAK, Src, paxillin, and p130Cas. In contrast, proliferation was
primarily driven by EGF stimulation, and was not affected by
HER2 expression levels.
From a mechanistic point of view, computational analysis of
the phosphoproteomic data set resulted in the identiﬁcation
of clusters of phosphorylation sites that are highly responsive
to particular sets of cellular stimulation conditions, linking
speciﬁc phosphorylation sites with activated receptor homo-
or heterodimers. In addition, PLSR analysis of the phospho-
proteomic and phenotypic data sets provided quantitative
weighting to describe the relationship between speciﬁc
phosphorylation sites and downstream biological behavior.
From this list, we were able to identify the phosphorylation
sites that are most strongly correlated with migration and
proliferation. Although some of these sites are intuitive (e.g.,
HER2Y1248withmigrationorEGFRY1173withproliferation),
the presence of unexpected phosphorylation sites (e.g.,
KIAA1217 Y393 with migration) in these lists gives a new
levelofinsightintothenatureofEGFRfamily-relatedsignaling
networks. Overall, the identiﬁcation of speciﬁc phosphoryla-
tion sites coupled to their relative weighting toward biological
outcome (proliferation and migration) enables a suite of
additional experiments in which speciﬁc proteins may be
targetedtoinhibitparticularbiologicalresponsestostimulation.
Materials and methods
Cell culture and stimulation
184A1 HMECs (Stampfer and Bartley, 1985) (HMEC parental) were a
kind gift from Martha Stampfer (Lawrence Berkeley Laboratory,
Berkeley, CA) via Steve Wiley (Paciﬁc Northwest National Laboratory,
Richland, WA) and were maintained in DFCI-1 medium supplemented
with 12.5ng/ml EGF, as described byHendriks et al (2003a). 184A1
HMECs clone 24H (HMECs overexpressing HER2 30-fold; Hendriks
et al, 2003a) (HMEC 24H) were a kind gift from Steve Wiley (Paciﬁc
NorthwestNationalLaboratories,Richland,WA) andweremaintained
in DFCI-1 medium supplemented with 12.5ng/ml EGFand 150mg/ml
of geneticin. Cells were washed with PBS and incubated for 12h in
serum-free media (DFCI-1 without EGF, bovine pituitary extract, or
fetal bovine serum) after 80% conﬂuence was reached in 15cm plates
(B2 10
7 cells). Synchronized cells were washed with PBS after
removal of media. Cells were then stimulated with 100ng/ml EGF or
80ng/ml HRG in serum-free media for 5, 10, or 30min, or left
untreated with serum-free media for 5min as control.
Sample preparation, peptide immunoprecipitation,
IMAC, and MS analysis
Samples were prepared and analyzed as described previously (Zhang
et al, 2005b). Detailed description is available in Supplementary
information.
Self-organizing maps
TheideabehindtheSOMistononlinearlytransformhigh-dimensional
input data into a lower dimensional display that consists of several
map units. Each map unit consists of a reference vector whose
dimension is the same as the dimension of an input pattern (Kohonen,
2001). The clustering is carried out in two steps. In the training phase,
theSOMalgorithmcomputesdistancebetweenaninputpatternandall
reference vectors. The map unit consisting of reference vector that
correlatesthebestwiththeinputpatternisdeclaredasthewinnermap
unit and is updated with maximal strength, whereas topologically
close map units are updated with gradually decreasing strength. This
process is executed using all 62 peptide proﬁles and repeated a few
times leading to self-organization. After the training phase, each
peptide is assigned to the map unit whose reference vector is most
similar to the input pattern.
The parameters for the SOM used in this study were as follows.
Topology of the map was chosen to be sheet, distance measure was
correlation, and the number of map units was chosen to be 5  
ﬃﬃﬃ
p
p
,
where p is the number of input vectors as suggested by Vesanto et al
(2000). We used the batch learning algorithm, and the neighborhood
function was chosen to be Gaussian with the parameters given by
Vesanto et al (2000). The SOM analysis was performed in MATLAB
with the publicly available SOM Toolbox (Vesanto et al, 2000).
We used the U-matrix method to identify a group of map units that
comprehend a cluster (Ultsch and Siemon, 1990). The U-matrix
illustrates Euclidean distances between the map units with colors.
Adjacent map units colored with blue shades constitute a cluster
(valleys) and the clusters are separated by red and yellow colors that
represent high distance between two map units (mountains). For each
cluster, wecomputedstatisticalsigniﬁcancewith the permutation test-
based method given by Hautaniemi et al (2003) as follows. First, we
computed correlation distances for all combinations of the peptide
proﬁlesinacluster.Ifthetwoproﬁlescorrelateperfectly,theirdistance
is zero and perfect negative correlation results in the distance value
two. Then, we computed the mean of these pairwise comparisons.
This was followed by choosing randomly the same number of proﬁles
as there are in the original cluster and computing all combinations of
thepairwisecorrelationdistances.Forexample,ifaclusterconsistedof
18peptides,werandomlychose18peptidesfromthesetof62peptides
and computed the mean of 153 correlation distance values (18 choose
2), which was compared to the mean of the peptide correlations in the
original cluster. If the mean distance of a randomly chosen set is less
than, or equal to, the original, we added one to counter. For each
cluster, we created 5000 samples and the ﬁnal P-value is computed by
dividing the counter by 5000. Large values suggest that the original
cluster may be owing to chance.
ELISA protocol for ErbB3 receptor quantiﬁcation
Reagents for the ErbB3 ELISAwere purchased from R&D Systems as a
Duoset DY348 (capture antibody, biotinylated detection antibody,
recombinant human Erb3, and streptavidin-HRP). The ELISA condi-
tions were those recommended by the manufacturer; additional
protocol details are available in Supplementary information.
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HMECs were plated on 24-well tissue culture plastic plates
(B1 10
4cells/cm
2) and grown for 24h to B60–70% conﬂuence.
The medium was then removed and cells were serum-starved as
previously described for 12–16h. Starved cells were then treated with
newserum-free media, serum-free media containing EGF (100ng/ml),
orserum-freemedia containingHRG (80ng/ml). Thecells were grown
for 15h at which time [
3H]thymidine (10mCi/ml) was added. After
10h, the cells were washed with cold PBS and treated with
trichloroacetic acid (5% w/v) at 41C. The resulting precipitate was
dissolved in NaOH (0.5N) and quantiﬁed using liquid scintillation
counting.
Migration
HMECs were seeded in 96-well tissue culture plastic plates (Packard
View PlateBlack,ref. 6005225)at conﬂuence (B50000cells/cm
2)and
allowed to adhere for 4–6h. Media were then removed and cells were
serum starved for 12–16h as described previously. Starved cells
were treated with 5-chloromethylﬂuorescein diacetate (CMFDA, 9mM
in serum-free media) for 30min. CMFDA-containing media were
removed and cells were then treated with new serum-free media,
serum-free media containing EGF (100ng/ml), or serum-free media
containing HRG (80ng/ml). Awound width B700mm was scraped in
each well and cell movement imaged every 15min for 12h using
Cellomics KineticScan. Kinetics of wound closure were quantiﬁed
using an in-house analysis software that calculated the wound area at
eachtimepointnormalizedbytheinitialwoundarea.Atimeaveraging
algorithm was used to average wound closure in four wells of equal
treatment into a single trajectory at 30min intervals. The trajectories
shown here have been additionally normalized to their 2h time points
forthepurposeofcomparingtreatments.Thewoundclosuredataused
in the described PLSR model are the linearly ﬁtted slope (2–5.5h) of
each trajectory shown.
Partial least-squares regression
Computational analysis was performed using the SIMCA-P 10.0
(Umetrics) software suite, as detailed elsewhere (Janes et al, 2004;
Gaudet et al, 2005). The software uses the nonlinear iterative partial
least-squares algorithm to perform decompositions and regressions.
The model was evaluated for goodness of ﬁt (R
2Y) and goodness of
prediction (Q
2), and was validated against overﬁtting via response
permutation (response matrix was randomly permuted 50 times and
Q
2 values were obtained for each run). All matrices were mean
centered and unit variance scaled (z-score normalized) before partial
least-squares analysis.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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